Alkermes Plc (NASDAQ:ALKS)

67.26
Delayed Data
As of Feb 16
 +3.51 / +5.51%
Today’s Change
46.43
Today|||52-Week Range
71.22
+22.89%
Year-to-Date
Alkermes PLC (ALKS) Files 10-K for the Fiscal Year Ended on December 31, 2017
Feb 16 / GuruFocus News - Paid Partner Content
Agios Pharmaceuticals (AGIO) Q4 Earnings: What's in Store?
Feb 09 / Zacks.com - Paid Partner Content
Alkermes (ALKS) Beats Q4 Earnings, Revenue Estimates
Feb 15 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Warming Up to Q4 Earnings: What's in Store?
Feb 09 / Zacks.com - Paid Partner Content
Do Options Traders Know Something About Alkermes (ALKS) Stock We Don't?
Feb 14 / Zacks.com - Paid Partner Content
5 Biotech Stocks Set to Trump Estimates This Earnings Season
Feb 06 / Zacks.com - Paid Partner Content
PRIMECAP Management Buys Alkermes PLC, Siemens AG, United Continental Holdings Inc, S...
Feb 13 / GuruFocus News - Paid Partner Content
Is a Beat in the Cards for ImmunoGen (IMGN) in Q4 Earnings?
Feb 05 / Zacks.com - Paid Partner Content
Shire (SHPG) to Report Q4 Earnings: What's in the Cards?
Feb 12 / Zacks.com - Paid Partner Content
Is a Beat in Store for Alexion (ALXN) This Earnings Season?
Feb 05 / Zacks.com - Paid Partner Content
Why Earnings Season Could Be Great for Alkermes (ALKS)
Feb 12 / Zacks.com - Paid Partner Content
Keryx (KERX) Warming Up to Q4 Earnings: What's in Store?
Feb 05 / Zacks.com - Paid Partner Content
Will Ocaliva Sales Dampen Intercept's (ICPT) Q4 Earnings?
Feb 12 / Zacks.com - Paid Partner Content
Strength Seen in Alkermes (ALKS): Stock Soars 8.7%
Feb 05 / Zacks.com - Paid Partner Content